| 臺大學術典藏 |
2021-09-17T03:21:21Z |
Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii)
|
Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Liao C.-H.; SHENG-KAI LIANG; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:21Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; SHENG-KAI LIANG; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:10Z |
Clinical characteristics of infections caused by Tsukamurella spp. and antimicrobial susceptibilities of the isolates
|
Liu C.-Y.; Lai C.-C.; MENG-RUI LEE; Lee Y.-C.; Huang Y.-T.; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:08Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
MENG-RUI LEE; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:07Z |
Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii)
|
MENG-RUI LEE; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Liao C.-H.; Liang S.-K.; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:04Z |
High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis
|
Chuang T.-Y.; Chang H.-T.; Chung K.-P.; Cheng H.-S.; Liu C.-Y.; Liu Y.-C.; Huang H.-H.; Chou T.-C.; Chang B.-L.; MENG-RUI LEE; Lin C.-J.; Lee S.-W.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-15T06:19:22Z |
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: A long-term cohort study on Matsu Islands
|
Chiang T.-H.; Chang W.-J.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chiu S.Y.-H.; Chen Y.-R.; Chuang S.-L.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; CHANG-CHUAN CHAN; Graham D.Y.; Chen H.-H.; Lee Y.-C. |
| 臺大學術典藏 |
2021-09-15T06:19:21Z |
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands
|
Chiang T.-H.; Maeda M.; Yamada H.; CHANG-CHUAN CHAN; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; Chen H.-H.; Ushijima T.; Graham D.Y.; Lee Y.-C. |
| 臺大學術典藏 |
2021-09-04T06:12:28Z |
Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients
|
Chu C.-H.; Yang A.-M.; JIA-HORNG KAO; Liu C.-Y.; Chang W.-H.; Yang W.-S. |
| 臺大學術典藏 |
2021-09-04T06:11:06Z |
Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
|
Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO; Chen K.-F. |
| 臺大學術典藏 |
2021-09-04T05:16:59Z |
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
|
Hu M.-H.; Huang T.-T.; Chao T.-I.; Chen L.-J.; Chen Y.-L.; Tsai M.-H.; Liu C.-Y.; JIA-HORNG KAO; Chen K.-F. |
| 臺大學術典藏 |
2021-09-02T00:08:50Z |
Modeling Interprocessor Communication and Performance Scalability for Distributed Deep Learning Systems
|
Lyu Y.-H;Liu C.-Y;Lee C.-P;Tu C.-H;Hung S.-H.; Lyu Y.-H; Liu C.-Y; Lee C.-P; Tu C.-H; Hung S.-H.; SHIH-HAO HUNG |
| 臺大學術典藏 |
2021-09-02T00:08:50Z |
Accelerating Variant Calling with Parallelized DeepVariant
|
Yang C.-H;Zeng J.-W;Liu C.-Y;Hung S.-H.; Yang C.-H; Zeng J.-W; Liu C.-Y; Hung S.-H.; SHIH-HAO HUNG |
| 臺大學術典藏 |
2021-09-02T00:04:10Z |
Systematic Hold-time Fault Diagnosis and Failure Debug in Production Chips
|
Liu C.-Y;Wu M.-T;Li J.C.-M;Bhargava G;Nigh C.; Liu C.-Y; Wu M.-T; Li J.C.-M; Bhargava G; Nigh C.; CHIEN-MO LI |
| 臺大學術典藏 |
2021-09-02T00:04:09Z |
Diagnosis technique for Clustered Multiple Transition Delay Faults
|
You Y.-S;Liu C.-Y;Wu M.-T;Chen P.-W;Li J.C.-M.; You Y.-S; Liu C.-Y; Wu M.-T; Chen P.-W; Li J.C.-M.; CHIEN-MO LI |
| 臺大學術典藏 |
2021-09-02T00:04:00Z |
Thermoelectric transport of the half-filled lowest Landau level in a p-type Ge/SiGe heterostructure
|
Liu X;Lu T.-M;Harris C.T;Lu F.-L;Liu C.-Y;Li J.-Y;Liu C.W;Du R.-R.; Liu X; Lu T.-M; Harris C.T; Lu F.-L; Liu C.-Y; Li J.-Y; Liu C.W; Du R.-R.; CHEE-WEE LIU |
| 臺大學術典藏 |
2021-09-01T01:54:11Z |
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
|
Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:10Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:03Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; Chen P.-J.; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:57Z |
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
|
Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:52Z |
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
|
Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; ANN-LII CHENG; Chen P.-J.; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:53:51Z |
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
|
Yu H.-C.; Chen H.-J.; Chang Y.-L.; Liu C.-Y.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:53:51Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:50Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu H.-C.; Hou D.-R.; Liu C.-Y.; Lin C.-S.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F. |
